- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Vitamin D and calcium supplementation reduces nonmelanoma skin cancer risk: Study
USA: Dietary supplementation with calcium alone or in combination with vitamin D reduces the risk of invasive cutaneous squamous cell carcinoma (SCC) but not basal cell carcinoma (BCC), suggests a recent study in the American Journal of Clinical Nutrition.
It is not known whether dietary supplementation with calcium or vitamin D helps in the prevention of keratinocyte carcinomas, also known as nonmelanoma skin cancers. Michael N Passarelli, Geisel School of Medicine at Dartmouth, Hanover, NH, USA, and colleagues aimed to determine whether daily vitamin D or calcium supplementation alters the risk of BCC or invasive SCC.
For the purpose, the researchers conducted the Vitamin D/Calcium Polyp Prevention Study -- a completed multicenter, double-blind, placebo-controlled, partial 2 × 2 factorial, randomized clinical trial of vitamin D, calcium, or both for the prevention of colorectal adenomas. The study included a total of 2259 men and women (45-75 years of age) who were recently diagnosed with colorectal adenoma. They were randomly assigned to 1000 IU/d of vitamin D3 or placebo and 1200 mg/d of calcium carbonate or placebo for 3 or 5 y, and followed after treatment ended. Reports of incident BCC or SCC were confirmed from pathology records.
Key findings of the study include:
- During a median follow-up of 8 y, 9% of the participants were diagnosed with BCC and 68 (3%) participants were diagnosed with SCC.
- BCC incidence was unrelated to treatment with vitamin D compared with no vitamin D (HR: 0.96), calcium compared with no calcium (HR: 1.01), and both agents compared with neither (HR: 0.99).
- SCC incidence was unrelated to treatment with vitamin D compared with no vitamin D (HR: 0.79), but there was suggestive evidence of beneficial treatment effects for calcium compared with no calcium (HR: 0.60) and both agents compared with neither (HR: 0.42).
"Calcium alone or in combination with vitamin D may reduce the risk of SCC, but not BCC," concluded the authors.
The study, "Risk of keratinocyte carcinomas with vitamin D and calcium supplementation: a secondary analysis of a randomized clinical trial," is published in the American Journal of Clinical Nutrition.
DOI:https://academic.oup.com/ajcn/advance-article-
MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at  editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751